Skip to main content
Log in

On drugs and dilators for achalasia

  • Editorial
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Traube M, McCallum RW: Calcium-channel blockers and the gastrointestinal tract. Am J Gastroenterol 79:892–896, 1984

    Google Scholar 

  2. Cohen S: Esophageal motility disorders and their response to calcium channel antagonists. The sphinx revisited. Gastroenterology 93:201–203, 1983

    Google Scholar 

  3. Triadafilopoulos G, Aaronson M, Sackel S, Burakoff R: Medical treatment of esophageal achalasia: a double blind crossover study with oral nifedipine, verapamil, and placebo. Dig Dis Sci (in press)

  4. Weiser HF, Lepsien G, Golenhofen K, Siewert R: Clinical and experimental studies on the effect of nifedipine on the esophagus and LES.In Gastrointestinal Motility in Health and Disease. HL Duthie (ed). Lancaster, MTP Press, 1978, pp 565–572

    Google Scholar 

  5. Blackwell JN, Holt S, Heading RD: Effect of nifedipine on esophageal motility and gastric emptying. Digestion 21:50–56, 1981

    Google Scholar 

  6. Gelfond M, Rozen P, Gilat T: Isosorbide dinitrate and nifedipine treatment of achalasia: A clinical, manometric and radionuclide evaluation. Gastroenterology 83:963–969, 1982

    Google Scholar 

  7. Bartolloti M, Labo G: Clinical and manometric effects of nifedipine in patients with esophageal achalasia. Gastroenterology 80:39–44, 1981

    Google Scholar 

  8. Traube M, Hongo M, Magyar L, McCallum RW: Effect of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions. JAMA 252:1733–1736, 1984

    Google Scholar 

  9. Traube M, Dubovik S, Lange RC, McCallum RW: The role of nifedipine therapy in achalasia: Results of a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 84:1259–1262, 1989

    Google Scholar 

  10. Hongo M, Traube M, McAllister RG, McCallum RW: Effects of nifedipine on esophageal motor function in humans: Correlation with plasma nifedipine concentration. Gastroenterology 86:8–12, 1984

    Google Scholar 

  11. Traube M, Hongo M, McAllister RG, McCallum RW: Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. J Clin Pharmacol 25:125–129, 1985

    Google Scholar 

  12. Traube M, Lange RC, McAllister RG, McCallum RW: Effect of nifedipine on gastric emptying in normal subjects. Dig Dis Sci 30:710–712, 1985

    Google Scholar 

  13. van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD: Negligible sublingual absorption of nifedipine. Lancet 2:1363–1365, 1987

    Google Scholar 

  14. Bourgeois N, Coffernils M, Buset M, Gelin M, Deltenre M, Panzer J-M, Cremer M: Management of dysphagia in suspected esophageal motor disorders. Dig Dis Sci 36:268–273, 1991

    Google Scholar 

  15. Rosenzweig S, Traube M: The diagnosis and misdiagnosis of achalasia. A study of 25 consecutive patients. J Clin Gastroenterol 11:147–153, 1989

    Google Scholar 

  16. Ott DJ, Richter JE, Chen YM, Wu WC, Gelfand DW, Castell DO: Esophageal radiography and manometry: Correlation in 172 patients with dysphagia. AJR 149:307–311, 1987

    Google Scholar 

  17. Hewson EG, Ott DJ, Dalton CB, Chen YM, Wu WC, Richter JE: Manometry and radiology. Comlementary studies in the assessment of esophageal motility disorders. Gastroenterology 98:626–632, 1990

    Google Scholar 

  18. Okike N, Payne WS, Neufeld DM, Bernatz PE, Pairolero PC, Sanderson DR: Esophagomyotomy versus forceful dilation for achalasia of the esophagus: Results in 899 patients. Ann Thorac Surg 28:119–125, 1979

    Google Scholar 

  19. Csendes A, Velasco N, Braghetto I, Henriquez A: A prospective randomized study comparing forceful dilatation and esophagomyotomy in patients with achalasia of the esophagus. Gastroenterology 80:789–795, 1981

    Google Scholar 

  20. Lishman AL, Dellipiani AW: Management of achalasia of the cardia by forced pneumatic dilatation. Gut 23:541–544, 1982

    Google Scholar 

  21. Fellows IW, Ogilvie AL, Atkinson M: Pneumatic dilation in achalasia. But 24:1020–1023, 1983

    Google Scholar 

  22. Reynolds JC, Parkman HP: Achalasia. Gastroenterol Clin North Am 18:223–255, 1989

    Google Scholar 

  23. Csendes A, Braghetto I, Henriquez A, Cortes C: Late results of a prospective randomized study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut 30:299–304, 1989

    Google Scholar 

  24. Barkin JS, Guelrud M, Reiner DK, Goldberg RI, Phillips RS: Forceful balloon dilation: An outpatient procedure for achalasia. Gastrointest Endosc 36:123–126, 1990

    Google Scholar 

  25. Traube M, Lagarde S, McCallum RW: Isolated hypertensive lower esophageal sphincter: Treatment of a resistant case by pneumatic dilatation. J Clin Gastroenterol 6:139–142, 1984

    Google Scholar 

  26. Friedin N, Traube M, Mittal R, McCallum RW: The hypertensive lower esophageal sphincter: Manometric and clinical aspects. Dig Dis Sci 34:1063–1067, 1989

    Google Scholar 

  27. Campo S, Traube M: Lower esophageal sphincter dysfunction in diffuse esophageal spasm. Am J Gastroenterol 84:928–932, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Traube, M. On drugs and dilators for achalasia. Digest Dis Sci 36, 257–259 (1991). https://doi.org/10.1007/BF01318192

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01318192

Navigation